STAT

2018 in limericks: The highs and lows from the life sciences

What a year it's been in the life sciences: CRISPR babies and IPOs galore, high-priced CAR-Ts and gene therapies. We remember it all with the 2018 edition of our year…

It’s been an eventful year in the life sciences, from the struggles of IBM Watson, to China’s twin CRISPR surprise, to a flurry of IPOs, to catching a serial killer with.)

You're reading a preview, sign up to read more.

More from STAT

STAT6 min read
Opinion: State Drug Importation Laws Undermine The Process That Keeps Our Supply Chain Safe
State legislators seem dangerously ill-informed about their states' troubled history of counterfeit drugs and are recreating the chaos that preceded the passage of a national track-and-trace system for prescription drugs.
STAT3 min read
Every Data Point Has A Face: What Michael Becker Taught Us
Michael Becker, the patient advocate and former biotech CEO who passed away this week, urged audiences to think beyond the word “data” when talking about studies of patients.
STAT4 min read
Opinion: Opioid Overdose Should Be Treated Like Attempted Suicide: With An Emergency Hold
Having first responders provide a dose of buprenorphine after an overdose rescue is like having them provide Prozac to someone they just pulled from the ledge of a 20-story building…